Feasibility Study - Filter Ventilation
Feasibility of Conducting a Telehealth Study Assessing the Removal of Filter Ventilation on Smoking Behavior and Biomarkers
1 other identifier
interventional
64
1 country
2
Brief Summary
This open label, between-subject, randomized multi-center pilot study will assess the feasibility of conducting a study remotely with telehealth visits to assess the effect of cigarettes with minimal filter ventilation vs. moderate filter ventilation on smoking behavior and biomarkers of tobacco toxicant exposure. Subjective measures, alveolar carbon monoxide, blood pressure and cigarettes per a day will be collected remotely. Biological samples will be collected at home and mailed to the study clinic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2020
CompletedFirst Posted
Study publicly available on registry
August 17, 2020
CompletedStudy Start
First participant enrolled
March 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedJanuary 12, 2026
January 1, 2026
1.2 years
August 12, 2020
January 8, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Feasibility of approach - Drop outs
Percent of drop-outs in baseline and post-randomization.
Baseline through Week 6
Feasibility of approach - Missing Data
Extent (percent) of missing data
Baseline through Week 6
Feasibility of approach - Participant Satisfaction
Degree of difficulty collecting data through telehealth visits, mailing in biosamples and self-purchase of cigarettes (descriptive statistics (e.g., percent or mean responses)
Baseline through Week 6
Secondary Outcomes (3)
Change in Total Nicotine Equivalents (TNE)
effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference
Change in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference
Change in mean cigarettes per day (CPD)
effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference
Study Arms (2)
Unventilated Filter Cigarette
EXPERIMENTALConventional cigarette with approximately 6-7% (non-menthol) and 5-6% filter ventilation (menthol).
Ventilated Filter Cigarette
ACTIVE COMPARATORConventional cigarette with approximately 22-26% (non-menthol) and 35-38% filter ventilation (menthol).
Interventions
Currently marketed unventilated cigarettes
Currently marketed ventilated cigarettes
Eligibility Criteria
You may qualify if:
- years of age or older
- Regular cigarette smoker
- Currently smoking an eligible brand
- Generally good health
- Access to smartphone or tablet and a device with a functioning camera for telehealth visits. Also must have internet access.
You may not qualify if:
- Unstable health
- Uncontrolled high blood pressure
- Pregnant or breast-feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Minnesota
Minneapolis, Minnesota, 55405, United States
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dorothy Hatsukami, PH.D
Masonic Cancer Center, University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2020
First Posted
August 17, 2020
Study Start
March 18, 2024
Primary Completion
June 5, 2025
Study Completion
June 30, 2025
Last Updated
January 12, 2026
Record last verified: 2026-01